Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Lin Chou

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 22, 2026
KLK10 Upregulation Drives Aggressiveness and Radioresistance and Has a Negative Prognostic Impact on Rectal CancerChia-Lin Chou, Cheng-Wei Lin, Wan-Shan Li, et al.
International Journal of Molecular Sciences|August 24, 2019
Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent ChemoradiotherapyHui-Ching Wang, Chia-Lin Chou, Ching-Chieh Yang, et al.
Journal of Clinical Medicine|July 24, 2021
Upregulated MUC2 Is an Unfavorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative CCRTChia-Lin Chou, Tzu-Ju Chen, Yu-Feng Tian, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRTTzu-Ju Chen, Yu-Feng Tian, Chia-Lin Chou, et al.
Journal of Biomedical Science|January 5, 2021
O6-methylguanine-DNA methyltransferase modulates cisplatin-induced DNA double-strand breaks by targeting the homologous recombination pathway in nasopharyngeal carcinomaShang-Hung Chen, Wen-Tsung Huang, Wan-Chen Kao, et al.
Life (Basel, Switzerland)|August 6, 2021
CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRTChia-Lin Chou, Tzu-Ju Chen, Yu-Feng Tian, et al.
Aging|May 6, 2024
Predictive value of FCGBP expression for treatment response and survival in rectal cancer patients undergoing chemoradiotherapyYu-Ting Su, Chung-Hsing Chen, Jui-Wen Kang, et al.
Oncology|July 6, 2025
Upregulated Claudin-18.2 Is a Poor Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent ChemoradiotherapyChia-Lin Chou, Han-Ping Hsu, Wan-Shan Li, et al.
NPJ Primary Care Respiratory Medicine|March 21, 2020
Independent risk factors for death in patients admitted for asthma exacerbation in TaiwanYuh-Lih Chang, Hsin-Kuo Ko, Meng-Shui Lu, et al.
International Journal of Clinical Oncology|May 27, 2021
High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRTTzu-Ju Chen, Chia-Lin Chou, Yu-Feng Tian, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 22, 2026
KLK10 Upregulation Drives Aggressiveness and Radioresistance and Has a Negative Prognostic Impact on Rectal CancerChia-Lin Chou, Cheng-Wei Lin, Wan-Shan Li, et al.
International Journal of Molecular Sciences|August 24, 2019
Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent ChemoradiotherapyHui-Ching Wang, Chia-Lin Chou, Ching-Chieh Yang, et al.
Journal of Clinical Medicine|July 24, 2021
Upregulated MUC2 Is an Unfavorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative CCRTChia-Lin Chou, Tzu-Ju Chen, Yu-Feng Tian, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRTTzu-Ju Chen, Yu-Feng Tian, Chia-Lin Chou, et al.
Journal of Biomedical Science|January 5, 2021
O6-methylguanine-DNA methyltransferase modulates cisplatin-induced DNA double-strand breaks by targeting the homologous recombination pathway in nasopharyngeal carcinomaShang-Hung Chen, Wen-Tsung Huang, Wan-Chen Kao, et al.
Life (Basel, Switzerland)|August 6, 2021
CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRTChia-Lin Chou, Tzu-Ju Chen, Yu-Feng Tian, et al.
Aging|May 6, 2024
Predictive value of FCGBP expression for treatment response and survival in rectal cancer patients undergoing chemoradiotherapyYu-Ting Su, Chung-Hsing Chen, Jui-Wen Kang, et al.
Oncology|July 6, 2025
Upregulated Claudin-18.2 Is a Poor Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent ChemoradiotherapyChia-Lin Chou, Han-Ping Hsu, Wan-Shan Li, et al.
NPJ Primary Care Respiratory Medicine|March 21, 2020
Independent risk factors for death in patients admitted for asthma exacerbation in TaiwanYuh-Lih Chang, Hsin-Kuo Ko, Meng-Shui Lu, et al.
International Journal of Clinical Oncology|May 27, 2021
High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRTTzu-Ju Chen, Chia-Lin Chou, Yu-Feng Tian, et al.
Pageof 6